A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China

NCT04121286 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer
Colorectal Cancer
Pancreatic Ductal Carcinoma
Esophageal Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Breast Cancer
Other Solid Tumors

Interventions

DRUG: JAB-3312

Sponsor

Allist Pharmaceuticals, Inc.